U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541859) titled 'Breast and Cervical Cancer Awareness Training in Visually Impaired Women' on Aug. 20, 2025... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541768) titled 'Training Medical Residents in the Use of the Venous Excess UltraSound (VExUS) Score for Be... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543224) titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Ev... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542197) titled 'Pre-anesthetic Teleconsultations During Pregnancy' on April 14. Brief Summary: Quality of... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541404) titled 'MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma' on April 06. Br... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542795) titled 'Evaluating The Use of CGF Plugs in Fresh Odontectomy Socket.' on April 15. Brief Summary:... Read More
Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 22 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More
Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More